Clinical chemistry market 2021 | Size, Share, Growth,
Pune, India, June 02, 2021 (GLOBE NEWSWIRE) – The world clinical chemistry market size is likely to gain momentum due to the increasing incidence of infectious diseases around the world. Fortune Business Insights describes the market growth trajectories in detail in its report titled “Global Clinical Chemistry Market Size, Share and Trend by Product Type (Analyzers, Reagents, and Consumables), by Application (General Chemistry Test, Test liver function, kidney Functional test, urinalysis, electrolyte panel, lipid profile, specialized chemical test, others), by end user (hospitals, diagnostic / pathology centers, outpatient surgery centers (ASC), others ) and geographic forecasts until 2026.
According to the current clinical chemistry market trends, the analyzer segment holds the maximum clinical chemistry market share in terms of product. This is due to the fact that analyzers are among the first line products used to perform the majority of clinical chemistry tests.
Request a copy of the research report
The report contains:
- A 360-degree overview of the market
- Growth drivers, constraints, challenges and opportunities
- Market segmentation details, interesting information and recent market development
- List of market players and key strategies adopted by them to gain competitive advantage in the market
- Other trends in the clinical chemistry market
Increasing prevalence of chronic diseases to drive the market
The increasing prevalence of acute, chronic and infectious diseases is driving the growth of clinical chemistry market. In addition to this, the increasing demand for accurate and rapid diagnostic procedures is also expected to help increase the clinical chemistry market revenue during the forecast period. In addition, a sedentary lifestyle, unhealthy diet and consumption habits are also expected to help increase the size of the clinical chemistry market in the coming years.
Moreover, increasing disposable income of people and adopting technologically advanced diagnostic procedures are expected to help the market to gain momentum during the forecast period.
On the other hand, factors such as lack of qualified professionals to perform clinical chemistry testing can hamper the overall size of the clinical chemistry market. This, together with the high cost of clinical chemistry testing, may restrain the growth of the clinical chemistry market in developing markets.
Please visit: https://www.fortunebusinessinsights.com/industry-reports/clinical-chemistry-market-100627
Asia-Pacific to become fastest growing region due to rapid development of health infrastructure
Geographically, North America holds the dominant share of the clinical chemistry market due to the presence of well-established healthcare infrastructure and facilities in the region. In addition, the initiatives and reimbursement mechanisms supported by the government will also help this region to continue to dominate in the years to come.
The European market is expected to experience significant growth due to the increase in healthcare infrastructure and the increasing prevalence of diseases such as cardiovascular disorders, high blood pressure and diabetes, lung disease and others. In addition, the Asia-Pacific market is expected to experience the greatest growth opportunity due to the fastest emerging markets in countries such as China, Japan and India and the rapid development of healthcare infrastructure in those countries.
Quick purchase Bowie Dick Test Pack Market
Launch of clinical chemistry products to increase competition in the market
Manufacturers in the clinical chemistry market are focusing on obtaining CE marks and product launches to gain a strong foothold in the competition. Hence, the competition is not only intense but also beneficial for the overall chemical market revenue during the forecast period.
Some of the latest industry developments in the The clinical chemistry market includes:
July 2015 – One of the largest clinical chemistry reagent companies, Sekisui Diagnostics, has announced the launch of its SEKURE brand of clinical chemistry reagents.
january 2017 – For their ALINITY CI-SERIES DIAGNOSIS SYSTEMS, Abbott has declared obtaining CE Mark (Certification Mark) for immunoassays and clinical chemistry diagnostics. Abbott also announced that it was awarded the CE market for its Alinity system used for plasma and blood screening.
January 2019 – COBAS PRO, an integrated solution in Serum Work Area, was launched by Hofmann-La-Roche Ltd in Serum Area. This is considered an important step in laboratory diagnosis capable of 2,200 tests on an hourly basis.
February 2019 – Fujifilm Corporation and JEOL have entered into a strategic collaboration for the overseas clinical chemistry analyzer industry.
Get your personalized research report:
Some of the major manufacturers in the clinical chemistry market include:
- Nova Biomedical
- Alfa Wassermann, Inc.
- Beckman Coulter, Inc.
- Ortho-Clinical Diagnosis
- F. Hoffmann-La Roche Ltée.
- Thermo Fisher Scientific
Segmentation of the global clinical chemistry market
By product type
• Reagents and consumables
• General chemistry test (panel of basic metabolites)
• Liver function test
• Kidney function test
• Urine analysis
• Electrolyte panel
• Lipid profile
• Specialized chemical test
By end user
• Diagnostic / pathology centers
• Ambulatory surgery centers (ASC)
• North America (United States and Canada)
• Europe (UK, Germany, France, Italy, Spain, Scandinavia and rest of Europe)
• Asia-Pacific (Japan, China, India, Australia, South-East Asia and the rest of Asia-Pacific)
• Latin America (Brazil, Mexico and the rest of Latin America)
• Middle East and Africa (South Africa, CCG and rest of Middle East and Africa)
Take a look at the related reports:
Dental chair market Global Size, Share & Trend by Design (Ceiling Mounted Design, Mobile Independent Design, Dental Chair Mounted Design), By Application (Dental Examination Chairs, Surgical Dental Chairs, Orthodontic Dental Chairs), By Product (Electric Dental Chairs) , non-motorized dental chairs), by end user (hospitals, dental clinics, outpatient surgery centers) and geographic forecast to 2021-2028
Atopic Dermatitis Treatment Market Size, share and global trend by drug class (corticosteroids, antihistamines, calcineurin inhibitors, interleukin inhibitors, topical phosphodiesterase-4, antibiotics, others), by route of administration (oral, topical, injectable), by distribution channel (hospital pharmacies), retail pharmacies, online pharmacies) and geographic forecasts until 2021-2028
Hairy Cell Leukemia Therapeutic Market Global Size, Share and Trend by Treatment (Chemotherapy, Biological Therapy, Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and Geographic Forecast to 2021-2028
Pain Management Software Market Global size, share and trend by technology (web software, cloud-based software), by end user (hospital, clinics, outpatient surgical centers, others) and geographic forecast to 2021-2028
Fortune Business Insights ™ delivers expert business analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions to our clients, helping them meet the specific challenges of their businesses. Our goal is to provide our clients with comprehensive market information, giving them a granular overview of the market in which they operate.
Our reports contain a unique blend of tangible information and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use cutting-edge research tools and techniques to compile comprehensive market research, interspersed with relevant data.
At Fortune Business Insights ™, we aim to highlight the most lucrative growth opportunities for our clients. We therefore offer recommendations allowing them to navigate more easily in technological and market-related developments. Our consulting services are designed to help organizations identify hidden opportunities and understand dominant competitive challenges.
Fortune Business Insights ™ Pvt. Ltd.
308, Supreme Headquarters,
Investigation n ° 36, Baner,
Pune – 411045, Maharashtra, India.
United States: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
LinkedIn | Twitter | Blogs